About StemRad
StemRad is an Industrial Goods & Manufacturing company based in Tel Aviv (Israel) founded in 2011. Selective radiation shielding apparel for critical organs is developed. StemRad has raised $6 million across 1 funding round from investors including Jeff Vinik. Its focus areas include Industrial Goods and Manufacturing and Manufacturing Services.
Company details
StemRad was founded in 2011 in Tel Aviv, Israel, within the radiation protection sector. Apparel and shielding technology focused on critical organs, such as bone marrow, are produced to reduce exposure from penetrating radiation. Applications span medical procedures, military operations, and space exploration. Mobility is preserved through lightweight designs that address drawbacks of traditional full-body shields. Operations emphasize material innovations for targeted protection.
- Headquarters Tel Aviv, Israel
- SectorsIndustrial Goods & Manufacturing
- Website stemrad.com
- Social LinkedIn
- Total Equity Funding$6M (USD)
in 1 rounds
- Latest Funding Round$6M (USD), Series C
Dec 2017
Funding Insights of StemRad
StemRad has successfully raised a total of $6M through 1 strategic funding round. The most recent funding activity was a Series C round of $6 million completed in December 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6M
- Total Rounds 1
- Last Round Series C — $6M
- First Round $6M
(Dec 2017)
- Investors Count 1
All 1 funding rounds of StemRad with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2017 | $6M | Series C | – | Jeff Vinik | – |
1 investors in total: 0 institutional and 1 angel.
Investors in StemRad
StemRad has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Jeff Vinik.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
JV Jeff Vinik | American investor, owner of Tampa Bay Lightning, active in sports and real estate. | unknown_ebf3cb00b25d4f318 |
Investor details for StemRad
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of StemRad
25 people are tracked at StemRad (5 in leadership, 16 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Oren Milstein | CEO And Chief Scientific Officer | Leadership |
Shahar Omri | CFO | Leadership |
Robert Busseau | Director, Business Development, 360 Gamma | Leadership |
Shirit Schwarz | Director Of Product Management | Leadership |
Bruce Zwiebel | Chief Medical Officer | Leadership |
Daniel Levitt | Co-Founder, Board Member & President | Board & advisors |
Alex Gurevich | Board Member | Board & advisors |
Ronen Melnik | Board Member | Board & advisors |
Scott J. Kelly | Advisor | Board & advisors |
Richard E. Champlin | Advisor | Board & advisors |
Robert Peter Gale | Advisor | Board & advisors |
Sean D. Lavine | Advisor | Board & advisors |
Thomas J. Macvittie | Advisor | Board & advisors |
Itzhak Mayo | Advisor | Board & advisors |
Jeff Vinik | Board Member | Board & advisors |
Andy Weber | Advisor | Board & advisors |
Kenneth R. Kase | Advisor | Board & advisors |
Benjamin Dekel | Advisor | Board & advisors |
Roger D. Kornberg | Advisor | Board & advisors |
Aaron Ciechanover | Advisor | Board & advisors |
5 more people are available in the full profile.
Complete people profiles for StemRad
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of StemRad
2 dated milestones of StemRad across 6 years, from founding to its latest funding, stage changes and deals.
- Founded StemRad is founded.
- Funding First funding round of $6.0M.
Web traffic of StemRad
The website of StemRad (stemrad.com) receives about 7.1K visits a month.
- Monthly visits7.1K
▲ 42.7% vs previous month
Websites whose visitors overlap most with StemRad. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
shebaonline.org | shebaonline.org | 100% | #601,255 | – | |
| docwirenews.com | 85% | #504,730 | View details | ||
radshield.com | radshield.com | 31% | #4,426,470 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Stemrad
Complete news archive for StemRad
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about StemRad
StemRad was founded in 2011 and raised its 1st funding round 6 years after it was founded.
StemRad is headquartered in Tel Aviv, Israel.
StemRad is a funded company, having raised a total of $6M across 1 funding round to date. The company's 1st funding round was a Series C of $6M, raised on Dec 2017.
StemRad was founded in 2011 in Tel Aviv, Israel, within the radiation protection sector. Apparel and shielding technology focused on critical organs, such as bone marrow, are produced to reduce exposure from penetrating radiation. Applications span medical procedures, military operations, and space exploration. Mobility is preserved through lightweight designs that address drawbacks of traditional full-body shields. Operations emphasize material innovations for targeted protection.
StemRad has 1 investor. Key investors include Jeff Vinik.